Description
NSE suspends trading in equity shares of Omkar Speciality Chemicals Limited (OMKARCHEM) effective April 29, 2026, due to capital reduction pursuant to an NCLT order dated July 31, 2025.
Summary
NSE has issued a circular (Ref No: NSE/CML/73932, Circular Ref. No: 0697/2026) notifying the suspension of trading in equity shares of Omkar Speciality Chemicals Limited (Symbol: OMKARCHEM) effective from the closing hours of April 28, 2026. The suspension is mandated under Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, triggered by a capital reduction pursuant to an NCLT (National Company Law Tribunal) order dated July 31, 2025.
Key Points
- Trading in OMKARCHEM equity shares is suspended effective April 29, 2026 (i.e., from closing hours of April 28, 2026)
- Suspension is under Regulation 3.1.2 of NSE Capital Market Trading Regulations Part A
- Reason: Capital Reduction pursuant to NCLT Order dated July 31, 2025
- Circular issued by Ruchi Jaiswal, Manager, NSE Listing Department
- Circular reference: NSE/CML/73932 | 0697/2026
Regulatory Changes
Under Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, NSE is empowered to suspend securities from trading. This action is a regulatory consequence of the NCLT-ordered capital reduction in Omkar Speciality Chemicals Limited, which necessitates halting normal equity trading.
Compliance Requirements
- All NSE members are notified and must cease trading in OMKARCHEM equity shares from the closing hours of April 28, 2026
- Members should inform their clients holding OMKARCHEM shares about the trading suspension
- No buy or sell orders for OMKARCHEM equity shares should be placed or accepted after the effective date
Important Dates
- NCLT Order Date: July 31, 2025 (underlying order for capital reduction)
- Circular Date: April 28, 2026
- Effective Date of Suspension: April 29, 2026 (from closing hours of April 28, 2026)
Impact Assessment
The suspension of OMKARCHEM equity shares will have a significant impact on existing shareholders and investors:
- Shareholders will be unable to trade (buy or sell) OMKARCHEM equity shares on NSE from April 29, 2026
- The capital reduction under the NCLT order likely implies a restructuring of the company’s equity, which may affect the value of shares held by investors
- Investors holding OMKARCHEM shares should review the NCLT order details and the company’s announcements to understand the implications of the capital reduction on their holdings
- The suspension may remain in effect until the capital reduction process is formally completed and NSE lifts the suspension
Impact Justification
Trading suspension directly affects shareholders and investors holding OMKARCHEM equity shares, with immediate market access cut off from April 29, 2026 onwards due to a court-ordered capital reduction.